Stocklytics Platform
Asset logo for symbol ICLR
ICON PLC
ICLR67
$128.04arrow_drop_up0.79%$1.00
Asset logo for symbol ICLR
ICLR67

$128.04

arrow_drop_up0.79%
Key Stats
Open$125.10
Prev. Close$126.99
EPS9.53
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range123.98
128.56
52 Week Range123.98
347.72
Ratios
EPS9.53
Fundamentals
Payout Ratio-
Industry average yield2.89%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

ICLR-
US Healthcare Sector-
US Market-
check_circle

ICLR / Market

ICLR exceeded the US Market which returned 0.03% over the last twenty four hours.
warning

ICLR / Healthcare Sector

ICLR lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

ICON PLC (ICLR) Statistics

ICON PLC (ICLR) is a globally recognized contract research organization (CRO) that provides a broad range of services to the pharmaceutical, biotechnology, and medical device industries. As of the latest statistics, the stock has shown steady growth over the past year, outperforming the sector. With a valuation that reflects the company's strong fundamentals, ICON PLC is regarded as an attractive investment option.
When considering its valuation metrics, ICON PLC demonstrates favorable ratios compared to its industry peers. The company's price-to-earnings ratio is competitive, indicating that investors are willing to pay a fair price for its earnings. Additionally, with a strong enterprise value-to-EBITDA ratio, ICON PLC shows efficiency in generating operating income relative to its overall enterprise value. These metrics highlight the company's solid financial position.
add ICON PLC to watchlist

Keep an eye on ICON PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has ICON PLC (ICLR) stock's performance compared to its sector and the market over the past year?

Over the past year, ICON PLC (ICLR) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, ICON PLC has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights ICON PLC's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of ICON PLC (ICLR) stock?

The PE (Price to Earnings) ratio of ICON PLC (ICLR) is currently 13.44. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of ICON PLC (ICLR) stock?

The Earnings Per Share (EPS) for ICON PLC (ICLR), calculated on a diluted basis, is $9.53. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of ICON PLC (ICLR) stock?

The operating margin for ICON PLC (ICLR) is 17.21%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of ICON PLC (ICLR) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of ICON PLC (ICLR) is $1.69B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does ICON PLC (ICLR) have?

ICON PLC (ICLR) has a total debt of $3.6B. The net debt, which accounts for cash and cash equivalents against the total debt, is $3.03B.

Take Your Investments to a Whole New Level